cay-10471 and Ureteral-Obstruction

Urinary excretion of lipocalin-type PGD(2) synthase (L-PGDS), which converts PG H(2) to PGD(2), increases in early diabetic nephropathy. In addition, L-PGDS expression in the tubular epithelium increases in adriamycin-induced nephropathy, suggesting that locally produced L-PGDS may promote the development of CKD. In this study, we found that L-PGDS-derived PGD(2) contributes to the progression of renal fibrosis via CRTH2-mediated activation of Th2 lymphocytes. In a mouse model, the tubular epithelium synthesized L-PGDS de novo after unilateral ureteral obstruction (UUO). L-PGDS-knockout mice and CRTH2-knockout mice both exhibited less renal fibrosis, reduced infiltration of Th2 lymphocytes into the cortex, and decreased production of the Th2 cytokines IL-4 and IL-13. Furthermore, oral administration of a CRTH2 antagonist, beginning 3 days after UUO, suppressed the progression of renal fibrosis. Ablation of IL-4 and IL-13 also ameliorated renal fibrosis in the UUO kidney. Taken together, these data suggest that blocking the activation of CRTH2 by PGD(2) might be a strategy to slow the progression of renal fibrosis in CKD.

Topics: Animals; Carbazoles; Disease Models, Animal; Fibrosis; Humans; Interleukin-13; Interleukin-4; Intramolecular Oxidoreductases; Kidney Diseases; Lipocalins; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Prostaglandin D2; Receptors, Immunologic; Receptors, Prostaglandin; RNA, Messenger; Signal Transduction; Sulfonamides; Th2 Cells; Ureteral Obstruction